We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

Fund managers haven’t disclosed any holdings of FBRX yet.

FBRX Hedge Fund Activity: Q1 2026 in Review

68 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2026, worth a combined $350M — up 11% from $315M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FBRX positions and 7 closed out — a net gain of 12 holders — while 21 added to existing stakes and 20 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $28.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $13.3M sold.

  • 68 institutional investors held Forte Biosciences (FBRX) as of Q1 2026, up from 59 in Q4 2025.
  • Funds reported $350M of Forte Biosciences stock for Q1 2026, up 11% quarter-over-quarter.
  • 19 funds opened new Forte Biosciences positions in Q1 2026 and 7 closed out, a net change of +12 holders.
  • The largest Forte Biosciences buyer in Q1 2026 was MPM BioImpact, an estimated $28.8M added.
  • The largest Forte Biosciences seller in Q1 2026 was Point72 Asset Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2026.